Dopl Technologies Raises $6.3 Million to Advance Telerobotic Ultrasound Platform Toward FDA Clearance
Dopl Technologies, a Bothell, Washington-based medical technology company developing a robotic ultrasound platform, has raised $6.3 million in a seed financing round to advance its proprietary telerobotic ultrasound ecosystem toward U.S. Food and Drug Administration (FDA) clearance. The investment, led by SpringTide Ventures, brings the company’s total funding to more than $8 million as Dopl prepares to move its technology through product validation, clinical evaluation, regulatory submission, and initial commercialization.
The financing represents a significant milestone for Dopl as it works to address one of the persistent challenges facing healthcare systems across the United States: limited access to specialized diagnostic imaging services. While ultrasound is widely used across cardiology, radiology, emergency medicine, obstetrics, and other clinical specialties, many hospitals and healthcare facilities—particularly those in rural and underserved communities—continue to face shortages of qualified sonographers and other specialized imaging professionals.
Dopl is developing a distributed care model designed to connect patients with skilled sonographers remotely. Through its telerobotic ultrasound platform, the company aims to allow trained professionals to perform diagnostic ultrasound examinations from a distance, potentially expanding access to specialized imaging without requiring every facility to maintain a full-time, on-site workforce.
Funding to Support Regulatory and Commercial Development
The new seed funding will support several key stages of Dopl’s product development and commercialization strategy. These activities include product verification and validation, FDA submission and clearance efforts, clinical evaluation, and the company’s initial market release.
Dopl’s product ecosystem includes three primary components: Traverse™, a remote robotic ultrasound system; Dopl Connect™, a secure connectivity and data platform; and SonoFlex™, a distributed clinical workforce and workflow management solution.
Together, these technologies are designed to create an integrated infrastructure for remote diagnostic ultrasound delivery. Rather than relying solely on a traditional model in which a sonographer must be physically present at the healthcare facility, Dopl’s approach is intended to separate the location of the patient from the location of the imaging professional.
The company’s platform is also hardware-agnostic. This means it is designed to integrate with commercially available robots, ultrasound systems, haptic controllers, and cameras. By working with existing technologies and hospital infrastructure, Dopl aims to facilitate faster implementation and potentially reduce the need for healthcare providers to replace their current imaging equipment.
The company believes this approach could be particularly valuable for health systems operating across multiple locations. A single network of specialized sonographers could potentially support patients across several hospitals, clinics, and remote facilities, helping providers address staffing shortages while improving the utilization of highly trained clinical professionals.
Addressing Unequal Access to Diagnostic Imaging
Access to healthcare remains uneven across the United States, with rural and geographically isolated communities frequently facing greater challenges in obtaining specialty services. Patients in these areas may need to travel significant distances to reach hospitals with specialized diagnostic capabilities. In some cases, a lack of qualified personnel can lead to delays in scheduling imaging procedures or require patients to travel to larger medical centers.
Ultrasound is an important diagnostic tool because it is noninvasive, does not use ionizing radiation, and can be used in a wide range of clinical settings. However, the availability of ultrasound services depends heavily on the presence of qualified professionals capable of performing and interpreting examinations.
Dopl’s distributed care model is intended to address this workforce challenge by allowing sonographers to perform examinations remotely. The company envisions a system in which a patient can receive an ultrasound examination at a local facility while a qualified sonographer operates the robotic equipment from another location.
This model could help expand access to specialty imaging in communities where recruiting and retaining experienced sonographers has proven difficult. It could also provide health systems with additional flexibility when managing demand across different locations.
According to Dopl, the company’s broader objective is to create a more accessible model for specialty care delivery. By combining robotics, secure connectivity, clinical workflows, and remote expertise, the company aims to help health systems provide diagnostic services closer to where patients live.
CareBridge Provides Interim Clinical Support
While Dopl continues to pursue FDA clearance for its telerobotic ultrasound ecosystem, the company has launched CareBridge™, an ultrasound service designed to address immediate patient and hospital needs.
CareBridge provides select hospitals with in-person coverage from traveling sonographers. The service is intended to ensure continuity of diagnostic ultrasound care while Dopl continues to develop and advance its robotic platform.
The company says the service has also provided an opportunity to establish relationships with healthcare providers and gain direct insights from patients and clinicians. These real-world experiences may help Dopl better understand the operational requirements associated with delivering ultrasound services across different healthcare environments.
In communities where CareBridge operates, Dopl reports that patients have experienced wait-time reductions of up to 90%. The company plans for select hospital systems currently using the service to become early pilot sites for transitioning imaging operations to Dopl’s telerobotic ecosystem once the technology receives FDA clearance.
This strategy could allow Dopl to build a base of potential early adopters while simultaneously gathering operational knowledge about the needs of hospitals and clinical teams. It also creates a pathway for the company to transition from a traditional staffing model toward a technology-enabled distributed care platform.
Combining Robotics, AI, and Clinical Expertise
Dopl’s team brings experience across several areas relevant to the development of robotic healthcare technologies, including robotics, artificial intelligence, medical devices, and clinical operations.
The company was founded by a former NVIDIA medical AI engineer together with practicing cardiologists and radiologists. The broader team includes professionals with experience at organizations such as Butterfly Network, Philips, Microsoft, and Amazon.
This combination of technical and clinical expertise reflects the complexity of developing medical robotics platforms. A successful telerobotic ultrasound system must address more than the mechanical movement of an ultrasound probe. It must also support clinical workflows, secure data transmission, patient safety, imaging quality, user interaction, and regulatory requirements.
The integration of haptic controllers and cameras is expected to play an important role in Dopl’s platform. Remote sonographers require appropriate control mechanisms and visual feedback to guide the examination and interact with the patient environment. The company’s technology is designed to combine these elements with robotic ultrasound equipment and secure connectivity.
Dopl’s approach also reflects a broader trend toward the use of physical artificial intelligence and robotics in healthcare. While many healthcare AI applications focus on software-based tasks such as data analysis, documentation, or decision support, physical AI systems combine intelligent software with hardware that can interact with the physical world.
CEO Highlights the Potential of Remote Care
Ryan James, PhD, CEO and co-founder of Dopl Technologies, said the new financing provides the company with the resources needed to move more rapidly through the regulatory process.
He emphasized the company’s goal of bringing remote robotic ultrasound services to patients who may otherwise need to travel long distances to access specialized care. According to James, Dopl’s long-term vision is to deliver specialty care more broadly through telerobotic and autonomous care technologies.
The company believes this could help address what it describes as a significant healthcare access divide affecting millions of people in the United States. By enabling clinical professionals to support patients remotely, Dopl aims to reduce geographic limitations associated with specialized diagnostic services.
The company’s strategy also reflects the growing interest in distributed healthcare delivery models. Instead of concentrating specialized expertise in major urban hospitals, healthcare technology companies are increasingly exploring ways to extend expertise to smaller facilities and underserved communities through digital connectivity, automation, and robotics.
SpringTide Ventures Leads Seed Financing
The funding round was led by SpringTide Ventures, which views Dopl as a company operating at the intersection of healthcare, robotics, and physical AI.
Austin Walters, co-founder and managing partner of SpringTide Ventures, said the firm believes Dopl has the potential to establish a new category in robotic care delivery. He pointed to the company’s combination of clinical traction, integrated technology, and experienced leadership as key factors supporting its investment.
SpringTide Ventures also highlighted the potential for Dopl to create a cost-efficient and revenue-generating model for health systems. One possible benefit of a distributed workforce model is that skilled sonographers could potentially work remotely while supporting patients in multiple locations.
The investment group is joined by WRF Capital, Tacoma Venture Fund, HeartX, Transform Health Ventures, Precursor Ventures, and additional early-stage institutional investors.
Tacoma Venture Fund previously served as the company’s pre-seed lead investor, while the participation of strategic, institutional, and community-focused investors gives Dopl a broad base of financial support as it advances toward the next stage of development.
Next Steps Toward FDA Clearance
With more than $8 million in total funding, Dopl is now positioned to focus on the technical, clinical, and regulatory milestones required to advance its telerobotic ultrasound platform.
The company’s immediate priorities include completing product verification and validation, conducting clinical evaluations, preparing regulatory submissions, and pursuing FDA clearance. The outcome of this process will be an important milestone for Dopl as it seeks to bring its technology into broader clinical use.
FDA clearance is expected to be central to the company’s planned transition from its CareBridge service model to its robotic ecosystem. Once regulatory requirements are met, Dopl plans to work with select hospital partners to pilot its telerobotic ultrasound technology.
The company’s longer-term vision extends beyond a single robotic ultrasound system. Through Traverse, Dopl Connect, and SonoFlex, the company is building a broader platform that combines robotic hardware, connectivity, clinical workforce management, and distributed healthcare delivery.
If successful, the model could help health systems expand diagnostic ultrasound capacity without relying exclusively on locally available specialists. It could also provide sonographers with greater flexibility while enabling patients to receive care closer to home.
As healthcare providers continue to face workforce shortages and increasing demand for diagnostic services, technologies that enable remote clinical expertise could become increasingly important. Dopl Technologies is seeking to position its telerobotic ultrasound platform as one potential solution to these challenges.
The latest financing gives the company additional resources to advance its regulatory and clinical development programs. As Dopl moves toward FDA submission and initial commercialization, the company will be closely watched by investors, healthcare providers, and the broader medical robotics industry as it works to demonstrate whether remote robotic ultrasound can become a scalable part of modern healthcare delivery.
Source link: https://www.businesswire.com/
